Overview of our drug development pipeline

Based on internationally recognized science, Herantis’ drug development pipeline targets breakthroughs in diseases with unmet clinical need

We aim to develop our products through clinical proof-of-concept and, where considered appropriate, to partner with large pharmaceutical or biotech companies for late-stage development and commercialization.

White papers

CDNF summary


xCDNF summary